Morning Overview on MSN
Engineered bacteria deliver chemo drug inside tumors in mice
Researchers at the National University of Singapore have engineered a common gut bacterium to carry a chemotherapy prodrug ...
MDNA113 is a novel IL-13Rα2 tumor-targeted and 'masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironme ...
Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as ...
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a ...
The funding, which ranks as one of the largest of its kind for a China-based drug startup, will support a portfolio of multifaceted antibodies the company believes to be advances over existing ...
Four presentations deliver new insights into zanidatamab, including its differentiated HER2 biologyVANCOUVER, British Columbia, March 18, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biot ...
India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results